Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Shah

Showing results (61-70 of 3,190) with videos related to

Pageof 319
Sort By:
Drug Safety|October 20, 2005
Drugs, QTc interval prolongation and final ICH E14 guideline : an important milestone with challenges aheadRashmi R Shah
Journal of Clinical Pharmacy and Therapeutics|October 13, 2018
Metamizole (dipyrone)-induced agranulocytosis: Does the risk vary according to ethnicity?Rashmi R Shah
The Indian Journal of Surgery|November 8, 2012
Doing less and less: Continuing evolution towards a less invasive approach to infected pancreatic necrosisSudeep R Shah
Drug Safety|November 27, 2007
Cardiac repolarisation and drug regulation: assessing cardiac safety 10 years after the CPMP guidanceRashmi R Shah
Journal of Clinical Pharmacy and Therapeutics|September 27, 2020
Chloroquine and hydroxychloroquine for COVID-19: Perspectives on their failure in repurposingRashmi R Shah
Indian Journal of Ophthalmology|September 1, 1972
Comparative study of mannitol, diamox, and glycerol on intra-ocular pressure and post-operation shallow chamberR R Shah
Drugs in Context|July 15, 2017
Advances in iron chelation therapy: transitioning to a new oral formulationNirmish R Shah
Proceedings (Baylor University. Medical Center)|June 15, 2026
Bridging the gap between guidelines and practice: comparative effectiveness of ustekinumab and vedolizumab in Crohn's diseaseRajesh R Shah
Drug Safety - Case Reports|September 22, 2017
Importance of Publishing Adverse Drug Reaction Case Reports: Promoting Public Health and Advancing Pharmacology and TherapeuticsRashmi R Shah
Therapeutic Advances in Drug Safety|September 2, 2017
Pharmacogenetics and precision medicine: Is inflammation a covert threat to effective genotype-based therapy?Rashmi R Shah
Pageof 319

Showing results (61-70 of 3,190) with videos related to

Sort By:
Pageof 319
Drug Safety|October 20, 2005
Drugs, QTc interval prolongation and final ICH E14 guideline : an important milestone with challenges aheadRashmi R Shah
Journal of Clinical Pharmacy and Therapeutics|October 13, 2018
Metamizole (dipyrone)-induced agranulocytosis: Does the risk vary according to ethnicity?Rashmi R Shah
The Indian Journal of Surgery|November 8, 2012
Doing less and less: Continuing evolution towards a less invasive approach to infected pancreatic necrosisSudeep R Shah
Drug Safety|November 27, 2007
Cardiac repolarisation and drug regulation: assessing cardiac safety 10 years after the CPMP guidanceRashmi R Shah
Journal of Clinical Pharmacy and Therapeutics|September 27, 2020
Chloroquine and hydroxychloroquine for COVID-19: Perspectives on their failure in repurposingRashmi R Shah
Indian Journal of Ophthalmology|September 1, 1972
Comparative study of mannitol, diamox, and glycerol on intra-ocular pressure and post-operation shallow chamberR R Shah
Drugs in Context|July 15, 2017
Advances in iron chelation therapy: transitioning to a new oral formulationNirmish R Shah
Proceedings (Baylor University. Medical Center)|June 15, 2026
Bridging the gap between guidelines and practice: comparative effectiveness of ustekinumab and vedolizumab in Crohn's diseaseRajesh R Shah
Drug Safety - Case Reports|September 22, 2017
Importance of Publishing Adverse Drug Reaction Case Reports: Promoting Public Health and Advancing Pharmacology and TherapeuticsRashmi R Shah
Therapeutic Advances in Drug Safety|September 2, 2017
Pharmacogenetics and precision medicine: Is inflammation a covert threat to effective genotype-based therapy?Rashmi R Shah
Pageof 319